Ladias, Bb Boy .

HRN: 25-65-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2024
AMPICILLIN 250MG (VIAL)
08/20/2024
08/27/2024
IV
160
Q12h
PNSB
Waiting Final Action 
08/20/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/20/2024
08/27/2024
IV
48mg
Q24h
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: